Cargando…
Antitumor activity of SA12, a novel peptide, on SKBr-3 breast cancer cells via the mitochondrial apoptosis pathway
Breast cancer is considered to be the most common malignancy in women. Treatment of breast cancer has been focused on molecular targeted therapy, and anticancer peptides are considered to be some of the most promising candidate drugs. In the current study, we used mRNA-peptide display technology to...
Autores principales: | Yang, Longfei, Cui, Ying, Shen, Jianjun, Lin, Fang, Wang, Xi, Long, Min, Wei, Junxia, Zhang, Huizhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354433/ https://www.ncbi.nlm.nih.gov/pubmed/25767377 http://dx.doi.org/10.2147/DDDT.S75780 |
Ejemplares similares
-
Peptide SA12 inhibits proliferation of breast cancer cell lines MCF-7 and MDA-MB-231 through G0/G1 phase cell cycle arrest
por: Yang, Longfei, et al.
Publicado: (2018) -
Honokiol inhibits the growth of SKBR3 cells
por: Shi, He, et al.
Publicado: (2020) -
PTPIP51 crosslinks the NFκB signaling and the MAPK pathway in SKBR3 cells
por: Dietel, Eric, et al.
Publicado: (2020) -
t10c12 Conjugated Linoleic Acid Suppresses HER2 Protein and Enhances Apoptosis in SKBr3 Breast Cancer Cells: Possible Role of COX2
por: Flowers, Margaret, et al.
Publicado: (2009) -
Astaxanthin Modulates Apoptotic Molecules to Induce Death of SKBR3 Breast Cancer Cells
por: Kim, Min Sung, et al.
Publicado: (2020)